You are here

AstraZeneca

AstraZeneca’s Imfinzi fails adjuvant trial in lung cancer

Pharmaphorum

Tue, 06/25/24 - 11:25 am

clinical trials

non-small cell lung cancer

Supreme Court gives pharma giants another chance to sidestep terrorism-funding case

Fierce Pharma

Mon, 06/24/24 - 10:08 pm

5 FDA Decisions to Watch in the Second Half of 2024

BioSpace

Mon, 06/24/24 - 11:29 am

Alzheimer's disease

advanced synovial sarcoma

Lykos Therapeutics

Bristol Myers Squibb

non-small cell lung cancer

AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial

BioSpace

Tue, 06/18/24 - 11:46 am

triple-negative breast cancer

AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer

Reuters

Mon, 06/17/24 - 11:31 am

endometrial cancer

AstraZeneca reports positive data from Phase III mantle cell lymphoma trial

Clinical Trials Arena

Mon, 06/17/24 - 11:21 am

clinical trials

mantle cell lymphoma

ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation

Fierce Pharma

Mon, 06/3/24 - 12:10 pm

non-small cell lung cancer

ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer

Fierce Pharma

Sun, 06/2/24 - 02:46 pm

AstraZeneca throws its hat into the oral PCSK9 ring

Pharmaphorum

Wed, 05/29/24 - 11:28 am

PCSK9 inhibitors

FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment

Reuters

Tue, 05/28/24 - 10:29 pm

Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far?

BioSpace

Fri, 05/24/24 - 11:14 am

AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets

Pharma Voice

Thu, 05/23/24 - 10:53 am

AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies

Fierce Biotech

Thu, 05/23/24 - 10:47 am

Nona Biosciences

SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca

BioPharma Dive

Wed, 05/22/24 - 11:24 am

AstraZeneca sets $80B revenue target, goal of 20 new drugs by 2030

BioSpace

Tue, 05/21/24 - 11:44 am

AstraZeneca’s Fasenra asthma drug shows promise for COPD treatment

Biopharma Reporter

Tue, 05/21/24 - 11:27 am

clinical trials

AstraZeneca to pay Pfizer $107.5M in damages in Tagrisso patent tussle

BioSpace

Mon, 05/20/24 - 11:29 am

Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD

Fierce Pharma

Mon, 05/20/24 - 11:25 am

AstraZeneca unveils plan for $1.5bn ADC plant in Singapore

Pharmaphorum

Mon, 05/20/24 - 10:57 am

drug manufacturing

antibody-drug conjugates

Biopharma M&A activity jumped 71% in Q1 2024

Medical Marketing and Media

Thu, 05/16/24 - 11:37 am

Gilead Sciences

CymaBay Therapeutics

Fusion Pharmaceuticals

Pages